Healthcare -
Biotechnology - NASDAQ - US
$ 0.7113
6.24 %
$ 42.1 M
Market Cap
-0.89
P/E
ELEV - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ELEV - Elevation Oncology, Inc.
48 M
LAST VALUE
-29.69%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR